BRPI0012553B8 - pastilha contendo cloridrato de ambroxol, seu processo de preparação e seu uso - Google Patents

pastilha contendo cloridrato de ambroxol, seu processo de preparação e seu uso

Info

Publication number
BRPI0012553B8
BRPI0012553B8 BRPI0012553A BR0012553A BRPI0012553B8 BR PI0012553 B8 BRPI0012553 B8 BR PI0012553B8 BR PI0012553 A BRPI0012553 A BR PI0012553A BR 0012553 A BR0012553 A BR 0012553A BR PI0012553 B8 BRPI0012553 B8 BR PI0012553B8
Authority
BR
Brazil
Prior art keywords
preparation process
tablet containing
ambroxol hydrochloride
containing ambroxol
ambroxol
Prior art date
Application number
BRPI0012553A
Other languages
English (en)
Other versions
BR0012553B1 (pt
BR0012553A (pt
Inventor
Maerz Frieder
Hans-Hermann Von Der Heydt Holger
Schmitt Horst
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7914872&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0012553(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR0012553A publication Critical patent/BR0012553A/pt
Publication of BR0012553B1 publication Critical patent/BR0012553B1/pt
Publication of BRPI0012553B8 publication Critical patent/BRPI0012553B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dry Formation Of Fiberboard And The Like (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Confectionery (AREA)
  • Cosmetics (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Fats And Perfumes (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)

Abstract

"pastilhas contendo ambroxol". a presente invenção refere-se a novas pastilhas com propriedades aperfeiçoadas, contendo a substância ativa ambroxol.
BRPI0012553A 1999-07-20 2000-07-07 pastilha contendo cloridrato de ambroxol, seu processo de preparação e seu uso BRPI0012553B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19933148A DE19933148A1 (de) 1999-07-20 1999-07-20 Ambroxolhaltige Lutschtablette
DE19933148.0 1999-07-20
PCT/EP2000/006437 WO2001005378A1 (de) 1999-07-20 2000-07-07 Ambroxolhaltige lutschtablette

Publications (3)

Publication Number Publication Date
BR0012553A BR0012553A (pt) 2002-04-16
BR0012553B1 BR0012553B1 (pt) 2014-05-27
BRPI0012553B8 true BRPI0012553B8 (pt) 2021-05-25

Family

ID=7914872

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0012553A BRPI0012553B8 (pt) 1999-07-20 2000-07-07 pastilha contendo cloridrato de ambroxol, seu processo de preparação e seu uso

Country Status (33)

Country Link
US (1) US6663889B1 (pt)
EP (2) EP1352646A3 (pt)
JP (1) JP3776041B2 (pt)
KR (1) KR100743846B1 (pt)
CN (1) CN1164263C (pt)
AT (1) ATE246493T1 (pt)
AU (1) AU776906B2 (pt)
BG (1) BG65503B1 (pt)
BR (1) BRPI0012553B8 (pt)
CA (1) CA2379314C (pt)
CZ (1) CZ301981B6 (pt)
DE (2) DE19933148A1 (pt)
DK (1) DK1200070T3 (pt)
EA (1) EA004044B1 (pt)
EE (1) EE04797B1 (pt)
ES (1) ES2173823T3 (pt)
HK (1) HK1045946B (pt)
HR (1) HRP20020050B1 (pt)
HU (1) HU229040B1 (pt)
IL (2) IL147261A0 (pt)
ME (1) MEP36808A (pt)
MX (1) MXPA02000546A (pt)
NO (1) NO331306B1 (pt)
NZ (1) NZ516987A (pt)
PL (1) PL197175B1 (pt)
PT (1) PT1200070E (pt)
RS (1) RS50246B (pt)
SI (1) SI1200070T1 (pt)
SK (1) SK284290B6 (pt)
TR (1) TR200200106T2 (pt)
UA (1) UA73313C2 (pt)
WO (1) WO2001005378A1 (pt)
ZA (1) ZA200200384B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125883A1 (de) 2001-05-28 2002-12-12 Serumwerk Bernburg Ag Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
DE10208313A1 (de) * 2002-02-27 2003-09-11 Boehringer Ingelheim Pharma Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
US20050075403A1 (en) * 2003-10-02 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of inflammation in the pharynx
ITMI20032463A1 (it) * 2003-12-16 2005-06-17 Advance Holdings Ltd Soluzione acquosa concentrata a base di ambroxolo
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
DE102005018561A1 (de) * 2005-04-21 2006-11-02 Giesecke & Devrient Gmbh Verfahren zum Betreiben eines Systems mit einem tragbaren Datenträger und einem Endgerät
DE102010009369A1 (de) 2010-02-25 2011-08-25 Boehringer Ingelheim International GmbH, 55218 Kindergesicherte Verpackung für Ambroxolhaltige Lutschtabletten
AU2011347257A1 (en) 2010-12-23 2013-05-23 Lectio Pharmaentwicklungs- Und Verwertungs Gmbh Aqueous solution of ambroxol
AU2012359165A1 (en) 2011-12-22 2014-07-10 Centogene Ip Gmbh Combination of a compound having the ability to rearrange a lysosomal enzyme and ambroxol and/or a derivative of ambroxol
WO2018089797A1 (en) 2016-11-14 2018-05-17 Mingwu Wang Formulations for the treatment of ocular surface diseases and related methods
MX2017014725A (es) * 2017-11-16 2019-05-17 Productos Farm S A De C V Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034975C2 (de) 1980-09-17 1986-11-27 Dr. Karl Thomae Gmbh, 7950 Biberach Arzneimittelkombination zur Behandlung infektiöser Atemwegerkrankungen
EP0138020B1 (de) 1983-09-17 1992-06-03 Dr. Karl Thomae GmbH Antiadhäsive Prophylactica und Arzneimittel enthaltend ein sekretolytisch wirksames Benzylaminderivat
IT1252185B (it) 1991-12-11 1995-06-05 Therapicon Srl Preparazioni farmaceutiche a liberazione programmata
DE4420735C2 (de) * 1994-06-15 1996-09-05 Allphamed Arzneimittel Gmbh Verfahren zur Herstellung mechanisch stabiler, sich mit hoher Auflösegeschwindigkeit auszeichnender Brausetabletten
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt

Also Published As

Publication number Publication date
HUP0202021A3 (en) 2004-05-28
HU229040B1 (en) 2013-07-29
DE50003209D1 (de) 2003-09-11
MEP36808A (en) 2011-02-10
HK1045946A1 (en) 2002-12-20
CZ301981B6 (cs) 2010-08-25
CN1364075A (zh) 2002-08-14
EP1352646A2 (de) 2003-10-15
EE04797B1 (et) 2007-04-16
DK1200070T3 (da) 2003-10-06
CN1164263C (zh) 2004-09-01
SK284290B6 (sk) 2005-01-03
KR20020012316A (ko) 2002-02-15
AU6269900A (en) 2001-02-05
KR100743846B1 (ko) 2007-08-02
ES2173823T1 (es) 2002-11-01
CZ20014633A3 (cs) 2002-03-13
AU776906B2 (en) 2004-09-23
YU3802A (sh) 2004-09-03
SK812002A3 (en) 2002-06-04
PL197175B1 (pl) 2008-03-31
HRP20020050B1 (en) 2004-06-30
IL147261A (en) 2006-12-31
WO2001005378A1 (de) 2001-01-25
HRP20020050A2 (en) 2003-06-30
NO331306B1 (no) 2011-11-21
IL147261A0 (en) 2002-08-14
ATE246493T1 (de) 2003-08-15
EP1352646A3 (de) 2004-01-07
BG65503B1 (bg) 2008-10-31
SI1200070T1 (en) 2003-12-31
MXPA02000546A (es) 2002-07-30
PT1200070E (pt) 2003-12-31
EA004044B1 (ru) 2003-12-25
EA200200091A1 (ru) 2002-06-27
EP1200070A1 (de) 2002-05-02
JP2003522125A (ja) 2003-07-22
JP3776041B2 (ja) 2006-05-17
US6663889B1 (en) 2003-12-16
BR0012553B1 (pt) 2014-05-27
NZ516987A (en) 2003-08-29
PL352276A1 (en) 2003-08-11
TR200200106T2 (tr) 2002-07-22
HUP0202021A2 (hu) 2002-11-28
DE19933148A1 (de) 2001-01-25
ES2173823T3 (es) 2004-04-16
ZA200200384B (en) 2002-10-30
UA73313C2 (uk) 2005-07-15
EE200200027A (et) 2003-04-15
CA2379314A1 (en) 2001-01-25
HK1045946B (zh) 2005-01-28
BR0012553A (pt) 2002-04-16
BG106316A (en) 2002-08-30
NO20020274L (no) 2002-03-13
EP1200070B1 (de) 2003-08-06
RS50246B (sr) 2009-07-15
CA2379314C (en) 2007-09-11
NO20020274D0 (no) 2002-01-18

Similar Documents

Publication Publication Date Title
CY1108587T1 (el) Φαρμακευτικη συνθεση για τροποποιημενη απελευθερωση ενος ευαισθητοποιητη ινσουλινης και μετφορμινης
HUP0203623A2 (hu) Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása
BRPI0012553B8 (pt) pastilha contendo cloridrato de ambroxol, seu processo de preparação e seu uso
EA200200571A1 (ru) Новая композиция и ее применение
DE69925133D1 (de) Pyrrolobenzodiazepine
ID28003A (id) Turunan-turunan adamantana
PT911340E (pt) Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos
BR0212921A (pt) Composição farmacêutica com base em fondant
BR9712808A (pt) Indol-3-glioxilamidas n-substituìdas com efeito antiasmático, anti-alérgico e imunossupressor/imunomodulador
BR9814592B1 (pt) composto azapolicìclico condensado com arila, composição farmacêutica contendo o mesmo e seu uso na fabricação de um medicamento.
GB2365772A (en) Factor
TR200201544T2 (tr) Fungusid aktivitesine sahip bileşik kombinasyonları.
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
ES2196620T3 (es) Formulacion de liberacion prolongada que contiene venlafaxina.
SE9802208D0 (sv) Novel compounds
DK1112060T3 (da) Doseringsform anvendende flydende formulering
EE04685B1 (et) Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks
YU36401A (sh) Farmaceutska kompozicija za stimulator osetljivosti na insulin sa modifikovanim ispuštanjem
ATE284878T1 (de) Pharmazeutische verbindungen mit serotonin rezeptor aktivität
UY26085A1 (es) N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica
BR0111055A (pt) Formulação farmacêutica, e, processo para a preparação e uso da mesma
NO20024590D0 (no) Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling
ITMI20000293A0 (it) Derivati del 3,9-diazabiciclo [3.3.1]nonano ad attivita' analgesica
BR0115281A (pt) Composições de n-(metiletilaminocarbonil)-4-(3-metilfenilamino)-3piri dilsulfonamida e oligossacarìdeos cìclicos

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/05/2014, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/07/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 07/07/2020